| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |